Skip to search formSkip to main contentSkip to account menu

Type II Endometrial Adenocarcinoma

Known as: Type II Endometrial Carcinoma 
A classification of primary endometrial adenocarcinomas that refers to clear cell adenocarcinoma, serous adenocarcinoma, and serous endometrial… 
National Institutes of Health

Related topics

Related topics

19 relations
Adenocarcinoma Cell with Intracytoplasmic MucinBody of uterusEndometriumEpithelial Cells

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Effect of Lymphadenectomy on Survival in Early-Stage Type II Endometrial Carcinoma and Carcinosarcoma
Purpose We aimed to investigate whether systematic pelvic and paraaortic lymph node dissection delivers any survival advantage in… 
Review
2017
Review
2017
Does hysteroscopy worsen prognosis in women with type II endometrial carcinoma?
Background Prior studies evaluating the impact of hysteroscopy on outcomes in endometrial cancer have predominantly evaluated… 
2017
2017
Clinicopathological differences between type I and type II endometrial carcinoma
Objective The aim of this study was to investigate the differences between type I and type II endometrial carcinoma (EC) as… 
2015
2015
Should Endometrial Clear Cell Carcinoma be Classified as Type II Endometrial Carcinoma?
Endometrial clear cell carcinomas (ECCCs) are considered to be Type II endometrial carcinomas, like uterine serous adenocarcinoma… 
Review
2014
Review
2014
Appendectomy with cytoreductive surgery for ovarian and type 2 endometrial carcinoma.
UNLABELLED There is considerable variation within and between cancer centers in the practice of appendectomy as part of… 
Review
2013
Review
2013
Adjuvant Radiation Therapy for Patients With Type II Endometrial Carcinoma: Impact on Tumor Recurrence and Survival
Purpose/Objective The optimal adjuvant treatment of type II endometrial carcinoma after hysterectomy remains controversial. The… 
Highly Cited
2012
Highly Cited
2012
p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans
Type II endometrial carcinomas are a highly aggressive group of tumour subtypes that are frequently associated with inactivation… 
2012
2012
Isolation and characterization of proliferative, migratory and multidrug-resistant endometrial carcinoma-initiating cells from human type II endometrial carcinoma cell lines.
Although the highly proliferative, migratory and multidrug resistant phenotype of human type II endometrial carcinoma… 
Highly Cited
2011
Highly Cited
2011
MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo
BackgroundOur previous studies have identified that miR-125b was overexpressed in type II endometrial carcinoma (EC) cells… 
Review
2007
Review
2007
Increased expression of hypoxia-inducible factor 1α in type I and type II endometrial carcinomas
Hypoxia-inducible factor 1α (HIF-1α) is a nuclear protein that is upregulated in many tumors and triggers biologic events… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)